RE-ENERGIZE now has 42 active sites participating in the trial. Recently, they enrolled the first 2 patients in Asia at a site in Thailand.
SUSTAIN has over 50% of enrollment completed! A new sub-study has been implemented looking at physical outcomes in post cardiac surgery patients
IMPACT With 7 active sites, more than 35% of the target enrollment has been reached
NEXIS has almost reached 35% of its recruitment target and is curruntly implmenting the NEXIS FLAME sub study across all sites.
EFFORT A substudy in 6-8 German and Swiss sites to assess the impact of the intervention on function outcomes similar to our NEXIS trial at hospital discharge is currently conducting training with all sites.